Leukemia, Myelomonocytic, Acute - 3 Studies Found
| Completed |
: Study of XIAP Antisense Given With Chemotherapy for Refractory/Relapsed AML : Leukemia, Myelomonocytic, Acute : 2006-08-10 : Drug: XIAP antisense 2 days loading dose followed by weekly 2hr infusion |
| Completed |
: Pilot Study of Erlotinib for the Treatment of Patients With de Novo Acute Myeloid Leukemia : Leukemia, Myelomonocytic, Acute : 2010-07-30 : Drug: Erlotinib Erlotinib will be administered orally at 150 mg once a day, continuously. Each cycle wil |
| Active, not recruiting |
: A Sequential Two-Stage Dose Escalation Study to Evaluate the Safety and Efficacy of Ruxolitinib : Myelomonocytic Leukemia : 2013-01-24 : Drug: Ruxolitinib In Phase I, participants will be allocated to twice a day (BID) doses of 10 mg/d up to |